Salary Range:CHF142,100.00 - CHF263,900.00 Job Description SummaryThe Director, Portfolio Analytics leads major portfolio analytics workstreams that inform enterprise, franchise, TA, and senior leadership decisions. The role shapes analytical approaches, interprets portfolio-level implications, advises stakeholders on value
JOB DESCRIPTION: At Abbott, were committed to helping people live their best possible life through the power of health. For more than 125 years, weve brought new products and technologies to the world in nutrition, diagnostics,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Company Description Sobi is an international biopharmaceutical company, dedicated to providing access to innovative treatments that transform life for people with rare diseases in the areas of haematology, immunology and specialty care. With our head office
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThis postdoctoral fellowship offers a unique opportunity to advance the use of artificial intelligence and machine learning for chemical synthesis and reactivity prediction in drug discovery. The successful
Salary Range:CHF133,700.00 - CHF248,300.00 Job Description SummaryLocation: Basel, Switzerland #onsite Role Purpose: The TRD QA Head CMC, ensures quality oversight of the CMC project portfolio and enabling portfolio within the CMC QA Team. He / she
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,
For one of our clients, a global pioneer in pharmaceuticals, we are currently looking for a Global/Principal Project Manager. General Information: Start Date: Planned Employment Duration: 12 months with the possibility of extension (depending on the
Key Responsibilities Identify clinical operations challenges and translate them into high-value Artificial Intelligence (AI) opportunities and product concepts. Define use cases, scope, value hypotheses, and requirements for prioritized products within the Global Clinical Operations AI portfolio. Evaluate
Bei Roche kannst du ganz du selbst sein und wirst für deine einzigartigen Qualitäten geschätzt. Unsere Kultur fördert persönlichen Ausdruck, offenen Dialog und echte Verbindungen. Hier wirst du für das, was du bist, wertgeschätzt, akzeptiert und
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)